Cargando…
Invasive pneumococcal diseases in children and adolescents– a single centre experience
BACKGROUND: S. pneumoniae is a major cause of meningitis, pneumonia and sepsis in children. In 2006 universal pneumococcal vaccination was recommended in Germany for all children up to their second birthday. We have compared the prevalence and outcome of IPD at a single hospital before and after the...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3984689/ https://www.ncbi.nlm.nih.gov/pubmed/24625087 http://dx.doi.org/10.1186/1756-0500-7-145 |
_version_ | 1782311468564217856 |
---|---|
author | Schnappauf, Christin Rodloff, Arne Siekmeyer, Werner Hirsch, Wolfgang Sorge, Ina Schuster, Volker Kiess, Wieland |
author_facet | Schnappauf, Christin Rodloff, Arne Siekmeyer, Werner Hirsch, Wolfgang Sorge, Ina Schuster, Volker Kiess, Wieland |
author_sort | Schnappauf, Christin |
collection | PubMed |
description | BACKGROUND: S. pneumoniae is a major cause of meningitis, pneumonia and sepsis in children. In 2006 universal pneumococcal vaccination was recommended in Germany for all children up to their second birthday. We have compared the prevalence and outcome of IPD at a single hospital before and after the introduction of vaccination. FINDINGS: 55 cases of IPD were identified over an 11 year period. Almost half of the patients were younger than 2 years of age. Most of the children were affected by pneumonia. The second highest incidence seen was for meningitis and sepsis. 17 patients exhibited additional complications. Significant pre-existing and predisposing disorders, such as IRAK 4 defect, ALPS or SLE were identified in 4 patients. Complete recovery was seen in 78% of affected children; 11% had a fatal outcome and 11% suffered from long term complications. Only 31% overall had been vaccinated. The most common serotype was 14. Serotypes not covered by any of the current vaccines were also found. Antibiotic treatment commenced with cephalosporins in over 90%. CONCLUSION: Frequency of IPD in our hospital did not decrease after initiation of the pneumococcal vaccination. This might be due to vaccinations not being administered satisfactorily as well as to poor education about the need of the vaccination. Pre-existing diseases must be monitored and treated accordingly and rare deficiencies taken into account when IPD takes a foudroyant course. In addition, antibiotic stewardship has been initiated at this hospital centre as a consequence of the high cephalosporin use detected in this study. |
format | Online Article Text |
id | pubmed-3984689 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2014 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-39846892014-04-14 Invasive pneumococcal diseases in children and adolescents– a single centre experience Schnappauf, Christin Rodloff, Arne Siekmeyer, Werner Hirsch, Wolfgang Sorge, Ina Schuster, Volker Kiess, Wieland BMC Res Notes Short Report BACKGROUND: S. pneumoniae is a major cause of meningitis, pneumonia and sepsis in children. In 2006 universal pneumococcal vaccination was recommended in Germany for all children up to their second birthday. We have compared the prevalence and outcome of IPD at a single hospital before and after the introduction of vaccination. FINDINGS: 55 cases of IPD were identified over an 11 year period. Almost half of the patients were younger than 2 years of age. Most of the children were affected by pneumonia. The second highest incidence seen was for meningitis and sepsis. 17 patients exhibited additional complications. Significant pre-existing and predisposing disorders, such as IRAK 4 defect, ALPS or SLE were identified in 4 patients. Complete recovery was seen in 78% of affected children; 11% had a fatal outcome and 11% suffered from long term complications. Only 31% overall had been vaccinated. The most common serotype was 14. Serotypes not covered by any of the current vaccines were also found. Antibiotic treatment commenced with cephalosporins in over 90%. CONCLUSION: Frequency of IPD in our hospital did not decrease after initiation of the pneumococcal vaccination. This might be due to vaccinations not being administered satisfactorily as well as to poor education about the need of the vaccination. Pre-existing diseases must be monitored and treated accordingly and rare deficiencies taken into account when IPD takes a foudroyant course. In addition, antibiotic stewardship has been initiated at this hospital centre as a consequence of the high cephalosporin use detected in this study. BioMed Central 2014-03-13 /pmc/articles/PMC3984689/ /pubmed/24625087 http://dx.doi.org/10.1186/1756-0500-7-145 Text en Copyright © 2014 Schnappauf et al.; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. |
spellingShingle | Short Report Schnappauf, Christin Rodloff, Arne Siekmeyer, Werner Hirsch, Wolfgang Sorge, Ina Schuster, Volker Kiess, Wieland Invasive pneumococcal diseases in children and adolescents– a single centre experience |
title | Invasive pneumococcal diseases in children and adolescents– a single centre experience |
title_full | Invasive pneumococcal diseases in children and adolescents– a single centre experience |
title_fullStr | Invasive pneumococcal diseases in children and adolescents– a single centre experience |
title_full_unstemmed | Invasive pneumococcal diseases in children and adolescents– a single centre experience |
title_short | Invasive pneumococcal diseases in children and adolescents– a single centre experience |
title_sort | invasive pneumococcal diseases in children and adolescents– a single centre experience |
topic | Short Report |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3984689/ https://www.ncbi.nlm.nih.gov/pubmed/24625087 http://dx.doi.org/10.1186/1756-0500-7-145 |
work_keys_str_mv | AT schnappaufchristin invasivepneumococcaldiseasesinchildrenandadolescentsasinglecentreexperience AT rodloffarne invasivepneumococcaldiseasesinchildrenandadolescentsasinglecentreexperience AT siekmeyerwerner invasivepneumococcaldiseasesinchildrenandadolescentsasinglecentreexperience AT hirschwolfgang invasivepneumococcaldiseasesinchildrenandadolescentsasinglecentreexperience AT sorgeina invasivepneumococcaldiseasesinchildrenandadolescentsasinglecentreexperience AT schustervolker invasivepneumococcaldiseasesinchildrenandadolescentsasinglecentreexperience AT kiesswieland invasivepneumococcaldiseasesinchildrenandadolescentsasinglecentreexperience |